In CRC such aberrant hypermethylation has been observed in the promoters of key tumor-suppressor genes, such as cyclin-dependent kinase inhibitor 2A (CDKN2A), MutL protein homolog 1 (MLH1), and APC [22]. This evidence concerns the gene CDKN2A and colorectal carcinoma.